9th International Neoantigen Summit 2026

 

As the only conference focused on neoantigens, the 9th International Neoantigen Summit returns to Amsterdam as the most timely and essential gathering for the field.

As your only chance this year to address the full translational journey – from antigen identification and validation through to biomarker strategy, clinical trial readouts and therapeutic efficacy – it’s not one to miss.

With 30% c-level attendees & 6 new speaking companies, including CellVax Therapeutics, Echo Immune, Epitopea and Khosen Bio, this convenes 70+ biopharma pioneers shaping the next generation of immunotherapies.

Every session is curated for relevance, and every interaction is designed to foster meaningful collaboration.

More Info

---

---